Efficacy of upadacitinib in a case of resistant lupus erythematosus tumidus

Journal of the European Academy of Dermatology and VenereologyEarly View LETTER TO THE EDITOR Efficacy of upadacitinib in a case of resistant lupus erythematosus tumidus V. Maione, Corresponding Author V. Maione [email protected] orcid.org/0000-0002-0420-5009 Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy Correspondence Vincenzo Maione, Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy. Email: [email protected]Search for more papers by this authorS. Bighetti, S. Bighetti Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorL. Bettolini, L. Bettolini orcid.org/0000-0003-4374-802X Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorP. Incardona, P. Incardona Department of Pathology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorP. Calzavara-Pinton, P. Calzavara-Pinton Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this author V. Maione, Corresponding Author V. Maione [email protected] orcid.org/0000-0002-0420-5009 Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy Correspondence Vincenzo Maione, Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy. Email: [email protected]Search for more papers by this authorS. Bighetti, S. Bighetti Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorL. Bettolini, L. Bettolini orcid.org/0000-0003-4374-802X Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorP. Incardona, P. Incardona Department of Pathology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this authorP. Calzavara-Pinton, P. Calzavara-Pinton Department of Dermatology, Spedali Civili, University of Brescia, Brescia, ItalySearch for more papers by this author First published: 01 November 2023 https://doi.org/10.1111/jdv.19604Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Patsinakidis N, Kautz O, Gibbs BF, Raap U. Lupus erythematosus tumidus: clinical perspectives. Clin CosmetInvestig Dermatol. 2019; 12: 707–719. 10.2147/CCID.S166723 CASPubMedWeb of Science®Google Scholar 2Zhou X, Yan J, Lu Q, Zhou H, Fan L. The pathogenesis of cutaneous lupus erythematosus: Theberrant distribution and function of different cell types in skin lesions. Scand J Immunol. 2021; 93:e12933. 10.1111/sji.12933 CASPubMedWeb of Science®Google Scholar 3van Vollenhoven RF, Hahn BH, Tsokos GC, Lipsky P, Gordon RM, Fei K, et al. Efficacy and safety of Ustekinumab in patients with active systemic lupus erythematosus: results of a phase II open-label extension study. J Rheumatol. 2022; 49(4): 380–387. 10.3899/jrheum.210805 PubMedWeb of Science®Google Scholar 4Kotyla PJ, Islam MA, Engelmann M. Clinical aspects of Janus kinase (JAK) inhibitors in the cardiovascular system in patients with rheumatoid arthritis. Int J Mol Sci. 2020; 21(19): 7390. 10.3390/ijms21197390 CASPubMedWeb of Science®Google Scholar 5Hu X, li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Sig Transduct Target Ther. 2021; 6:402. 10.1038/s41392-021-00791-1 PubMedWeb of Science®Google Scholar 6Moura RA, Fonseca JE. JAK inhibitors and modulation of B cell immune responses in rheumatoid arthritis. Front Med (Lausanne). 2021; 5(7):607725. 10.3389/fmed.2020.607725 Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation